Consensus Statement

Consensus Statement

Regulatory and Scientific Issues in Studies to Evaluate Sexual Dysfunction in Antidepressant Drug Trials

August 26, 2015

Consensus Statement

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

March 25, 2015

Consensus Statement

Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations

January 15, 2013

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

August 16, 2010

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

July 13, 2010

Consensus Statement

Consensus Statement: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes

February 1, 2004